Pharmaceutical Executive March 16, 2020
Jill Wechsler

Now officially a worldwide pandemic, the biomedical research community is rushing to develop treatments and preventives to halt the spread and severity of the COVID-19 virus. Political infighting has stymied an effective response in the US, with much finger-pointing on all sides. As the severity of the disease becomes more starkly apparent, schools and communities have shut down and cancellations have hit most travel, sports, and business and professional meetings.

An efficient effort by the US health care system to identify and isolate infected individuals has been undermined by a lack of fast and available diagnostics, and remedies have been derailed by political missteps and administrative failings. Short supplies of test kits and of reagents have forced clinics and hospitals...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Provider, Supply Chain, Technology, Trends
Fauci allies, Covid vaccine officials get ax at NIH
Mapped: The most (and least) healthy cities in America
A new COVID variant is on the rise. Here's what to know about LP.8.1
Will the COVID-19 pandemic ever end? What Americans say in new poll
23andMe is potentially selling more than just genetic data. Survey info is just as much a privacy problem

Share This Article